Completed Infection & Immunity Brain & Nervous System

Molecular mechanism of innate signalling in the immune and nervous system.

In plain English

AI plain-English summary

The body’s frontline immune defences and the brain’s waste-cleaning cells share a common molecular switch—and this project will map exactly how that switch works in both settings. Toll-like receptors (TLRs) are proteins that normally detect invading microbes and trigger inflammation. But in the brain, the same receptors can become chronically activated in microglia, the resident immune cells, contributing to neuron death in Parkinson’s disease. The researcher will use structural biology to determine how TLRs assemble into signalling platforms, and how a protein called LRRK2—a known genetic risk factor for Parkinson’s—interacts with these receptors. They will also identify which cellular factors activate TLRs in the absence of infection, and which genes and proteins are switched on when microglia become toxic. This is fundamental science. It does not promise a new drug tomorrow. But understanding the molecular handshake between TLRs and LRRK2 could reveal specific points where the neurodegenerative cascade might be interrupted. Past work on innate immune signalling has already led to therapies for autoimmune diseases; a similar mechanistic grasp of TLR-driven neurotoxicity could open routes to slow or halt Parkinson’s progression.

View original technical description
My goal is to take an inter-disciplinary approach to address two major objectives. Firstly I aim to understand the supramolecular organization of innate immune signaling platforms, their dynamics and the molecular basis of cooperative assembly and signaling crosstalk with reference particularly to the Toll and Toll-like receptors (TLR). We will define the protein-protein interfaces between receptors, ligands and adaptors that are critical to TLR signal transduction using an integrated structural biology approach. We will also study the molecular basis of signalling cross-talk from the TLR pathway with reference to the adaptor BCAP, that links to PI3 kinase and TRIF which couples interferon beta and apoptotic signals. Our second objective is to study the role of Toll and TLRs in neurogenesis and neurodegeneration. Specifically we will determine how LRRK2, a protein kinase that is a genetic risk factor for Parkinson's disease, and TLRs are activated in microglia and how activation is linked to neurotoxicity. Specifically we will analyse what cellular factors activate TLRs in the absence of infection and what proteins associate with LRRK2 in the presence and absence of signalling. We will also use transcriptomic and proteomic approaches to identify which genes are expressed when microglia are activated and what proteins are substrates for the LRRK2 kinase. An understanding of the events that initiate and maintain neurodegeneration will lead to the development of novel therapi es aimed at inhibiting these processes.

View the original record at the funder ↗

Researchers

Nicholas Gay (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Structure and regulation of the cytoplasmic membrane complexes formed during signal transduction by the Toll-like receptors
Tolls and neurotrophins in central nervous system regeneration and repair in Drosophila
Small molecule agonists and antagonists of inflammatory responses mediated by Toll- and Nod- like receptors
Towards a molecular understanding of Myddosome organization and regulation of IRAK kinase activity
Defining TILRR regulation of distinct IL-1RI responses using systems biology

Original classification

Investigator Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.